[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Resmed Inc (RMD)

Resmed Inc (RMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 28,436,776
  • Shares Outstanding, K 145,056
  • Annual Sales, $ 5,146 M
  • Annual Income, $ 1,401 M
  • EBIT $ 1,941 M
  • EBITDA $ 2,177 M
  • 60-Month Beta 0.80
  • Price/Sales 5.48
  • Price/Cash Flow 17.35
  • Price/Book 4.34

Options Overview Details

View History
  • Implied Volatility 30.51% (+0.03%)
  • Historical Volatility 33.90%
  • IV Percentile 57%
  • IV Rank 31.90%
  • IV High 52.18% on 10/30/25
  • IV Low 20.36% on 08/13/25
  • Expected Move (DTE 11) 5.61 (2.86%)
  • Put/Call Vol Ratio 0.11
  • Today's Volume 531
  • Volume Avg (30-Day) 583
  • Put/Call OI Ratio 1.99
  • Today's Open Interest 15,679
  • Open Int (30-Day) 15,266
  • Expected Range 190.43 to 201.65

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 20 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $2.90
  • Number of Estimates 5
  • High Estimate $2.92
  • Low Estimate $2.88
  • Prior Year $2.55
  • Growth Rate Est. (year over year) +13.73%

Price Performance

See More
Period Period Low Period High Performance
1-Month
180.26 +8.75%
on 06/02/26
213.53 -8.19%
on 05/06/26
-11.84 (-5.70%)
since 05/05/26
3-Month
180.26 +8.75%
on 06/02/26
253.26 -22.59%
on 03/06/26
-59.28 (-23.22%)
since 03/05/26
52-Week
180.26 +8.75%
on 06/02/26
293.81 -33.28%
on 08/22/25
-53.65 (-21.49%)
since 06/05/25

Most Recent Stories

More News
3 Big Reasons RMD Should Be On Your Watchlist

3 Big Reasons RMD Should Be On Your Watchlist

RMD : 196.04 (+0.89%)
Resmed Completes Acquisition of Noctrix Health, Expanding Clinical Sleep Health Portfolio

SAN DIEGO, June 01, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced it has completed...

RMD.AX : 27.640 (+4.30%)
RMD : 196.04 (+0.89%)
Do Wall Street Analysts Like ResMed Stock?

ResMed continues to command steady Wall Street confidence despite recent stock pressure and a few bumps along the road.

XLV : 153.01 (+0.61%)
$SPX : 7,383.74 (-2.64%)
RMD : 196.04 (+0.89%)
2 Healthcare Stocks to Research Further and 1 We Find Risky

2 Healthcare Stocks to Research Further and 1 We Find Risky

TECH : 51.99 (-2.24%)
HCA : 372.13 (+2.85%)
RMD : 196.04 (+0.89%)
3 Large-Cap Stocks to Consider Right Now

3 Large-Cap Stocks to Consider Right Now

ALL : 221.01 (+4.82%)
AMP : 454.66 (-0.09%)
RMD : 196.04 (+0.89%)
Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference

SAN DIEGO, May 19, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Aaron Bloomer, chief financial officer, will attend the...

RMD.AX : 27.640 (+4.30%)
RMD : 196.04 (+0.89%)
Resmed and ÅŒURA Partner to Expand Access to Sleep Health Education and Care

SAN DIEGO, May 19, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, and ŌURA, maker of the world’s...

RMD.AX : 27.640 (+4.30%)
RMD : 196.04 (+0.89%)
ResMed’s Q1 Earnings Call: Our Top 5 Analyst Questions

ResMed’s Q1 Earnings Call: Our Top 5 Analyst Questions

RMD : 196.04 (+0.89%)
S&P 500 and Nasdaq 100 Post Record Highs on Solid Earnings

The S&P 500 Index ($SPX ) (SPY ) on Friday closed up +0.29%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down -0.31%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.94%. June E-mini...

MSTR : 120.44 (-6.90%)
ALK : 42.82 (+0.30%)
AAPL : 307.34 (-1.25%)
INTU : 296.76 (-1.73%)
SNDK : 1,559.32 (-11.39%)
DDOG : 234.11 (-3.90%)
GLXY : 25.14 (-11.51%)
VEEV : 172.61 (-3.35%)
$IUXX : 28,957.60 (-4.77%)
AMGN : 349.58 (+1.15%)
COIN : 152.40 (-7.15%)
CLX : 94.14 (+5.03%)
Stocks Climb on Strong Earnings and Crude Oil Weakness

The S&P 500 Index ($SPX ) (SPY ) today is up +0.62%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.02%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.10%. June E-mini S&P futures (ESM26...

MSTR : 120.44 (-6.90%)
AAPL : 307.34 (-1.25%)
INTU : 296.76 (-1.73%)
ADI : 401.39 (-6.38%)
DDOG : 234.11 (-3.90%)
GLXY : 25.14 (-11.51%)
VEEV : 172.61 (-3.35%)
$IUXX : 28,957.60 (-4.77%)
AMGN : 349.58 (+1.15%)
COIN : 152.40 (-7.15%)
CLX : 94.14 (+5.03%)
ZNU26 : 109-025s (-0.47%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory...

See More

Key Turning Points

3rd Resistance Point 204.37
2nd Resistance Point 202.18
1st Resistance Point 199.11
Last Price 196.04
1st Support Level 193.85
2nd Support Level 191.66
3rd Support Level 188.59

See More

52-Week High 293.81
Fibonacci 61.8% 250.44
Fibonacci 50% 237.04
Fibonacci 38.2% 223.64
Last Price 196.04
52-Week Low 180.26

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.